CRNX Crinetics Pharmaceuticals, Inc. logo

CRNX Crinetics Pharmaceuticals, Inc.

Healthcare
$36.78-0.05%ClosedMarket Cap: $3.88B

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

250

13F Shares

111,610,568

Ownership %

118.5%

New Positions

50

Increased Positions

146

Closed Positions

33

Reduced Positions

77

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
MNTLTema Neuroscience And Mental Health ETF13,0663.54%
SBIOALPS Medical Breakthroughs ETF85,2322.35%
XPH159,6421.87%
FMEDFidelity Disruptive Medicine ETF19,0001.17%
BBPVirtus Biotech ETF16,7211.12%
KTD286,5201.01%
IHEiShares U.S. Pharmaceuticals ETF286,5201.01%
ANOGX733,1140.70%
VGHCX3,188,0550.37%
VGHAX3,188,0550.37%
IBBiShares Biotechnology ETF726,4280.32%
DWASInvesco Dorsey Wright SmallCap Momentum ETF27,9220.28%
VTWG89,5950.25%
VEXRX1,119,6720.25%
VEXPX1,119,6720.25%
IWOiShares Russell 2000 Growth ETF796,1070.23%
NLO796,1070.23%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF39,2130.20%
TMSLT. Rowe Price Small-Mid Cap ETF81,8130.19%
JHSCJohn Hancock Investments - Multifactor Small Cap ETF21,4790.15%